115 related articles for article (PubMed ID: 9301303)
21. Blood group antibodies and their significance in transfusion medicine.
Poole J; Daniels G
Transfus Med Rev; 2007 Jan; 21(1):58-71. PubMed ID: 17174221
[TBL] [Abstract][Full Text] [Related]
22. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
[TBL] [Abstract][Full Text] [Related]
23. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
24. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
[TBL] [Abstract][Full Text] [Related]
25. Frequencies of blood type A, B and AB in non-pedigree domestic cats in Turkey.
Arikan S; Gurkan M; Ozaytekin E; Dodurka T; Giger U
J Small Anim Pract; 2006 Jan; 47(1):10-3. PubMed ID: 16417604
[TBL] [Abstract][Full Text] [Related]
26. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
27. Transfusion medicine illustrated: in vivo red cell agglutination in a small child.
Wong E; Deka B
Transfusion; 2005 Jan; 45(1):1. PubMed ID: 15647008
[No Abstract] [Full Text] [Related]
28. Enhanced detection of blood bank sample collection errors with a centralized patient database.
MacIvor D; Triulzi DJ; Yazer MH
Transfusion; 2009 Jan; 49(1):40-3. PubMed ID: 18798804
[TBL] [Abstract][Full Text] [Related]
29. Transfusion medicine illustrated. Detection of mixed-field agglutination due to loss of red cell antigen in hematopoietic malignancy.
Sheppard CA; O'Reilly KC; Schniederjan SD; Hillyer CD; Roback JD
Transfusion; 2006 Sep; 46(9):1463-4. PubMed ID: 16965568
[No Abstract] [Full Text] [Related]
30. Medicolegal assessment of blood transfusion errors--an interdisciplinary challenge.
Padosch SA; Schmidt PH; Pedal I; Franchy C; Hoch J; Madea B
Forensic Sci Int; 2007 Oct; 172(1):40-8. PubMed ID: 17222999
[TBL] [Abstract][Full Text] [Related]
31. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
Shulman IA
Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
[TBL] [Abstract][Full Text] [Related]
32. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
33. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
34. ABO incompatible stem cell transplantation in children does not influence outcome.
Helming AM; Brand A; Wolterbeek R; van Tol MJ; Egeler RM; Ball LM
Pediatr Blood Cancer; 2007 Sep; 49(3):313-7. PubMed ID: 16960869
[TBL] [Abstract][Full Text] [Related]
35. Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.
Özen M; Yılmaz S; Özkan T; Özer Y; Pekel AA; Sunguroğlu A; Gürman G; Arslan Ö
Turk J Haematol; 2018 Mar; 35(1):54-60. PubMed ID: 28533197
[TBL] [Abstract][Full Text] [Related]
36. Detection of IgG anti-A/B must be essential for safe transfusion support in patients undergoing ABO incompatible allogeneic HSCT.
Liu F; Li G; Mao X; Hu L
Transfus Apher Sci; 2011 Apr; 44(2):123-7. PubMed ID: 21320800
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
38. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients?
Shulman IA; Kent D
Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957
[TBL] [Abstract][Full Text] [Related]
39. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
40. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
